An Inside Look At The World's Largest Charitable Funder of Cancer Research

Comments

Cancer drug development has shifted in recent years as traditional chemotherapies give way to targeted therapies and therapeutic antibodies. Some of the most exciting research in this space is being done by London-based charity Cancer Research UK.

[Join co-hosts Cancer Research UK and Medidata for our upcoming Twitter chat, “Patient Centricity in Clinical Trials,” on May 19, 11 am EST / 4pm BST. We’ll discuss the challenges, opportunities and value that a patient-centric model presents for drug development.]

About Author

Jonathan Stone

Jonathan is a regional account manager for EMEA at Medidata.